Wells Fargo’s Compass Therapeutics CMPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$253K Sell
47,740
-97,058
-67% -$560K ﹤0.01% 4568
2025
Q4
$778K Buy
144,798
+76,625
+112% +$354K ﹤0.01% 4154
2025
Q3
$239K Buy
68,173
+15,449
+29% +$48.8K ﹤0.01% 4838
2025
Q2
$137K Sell
52,724
-8,489
-14% -$17.5K ﹤0.01% 4993
2025
Q1
$116K Buy
61,213
+1,353
+2% +$3.6K ﹤0.01% 5032
2024
Q4
$86.8K Buy
59,860
+13,038
+28% +$21.7K ﹤0.01% 5276
2024
Q3
$86.2K Buy
46,822
+2,012
+4% +$2.51K ﹤0.01% 5103
2024
Q2
$44.8K Buy
44,810
+12,991
+41% +$19K ﹤0.01% 5342
2024
Q1
$63K Buy
31,819
+4,091
+15% +$7.07K ﹤0.01% 5162
2023
Q4
$43.3K Buy
27,728
+5,536
+25% +$9.58K ﹤0.01% 5329
2023
Q3
$43.7K Sell
22,192
-12,928
-37% -$32K ﹤0.01% 5247
2023
Q2
$112K Buy
35,120
+33,783
+2,527% +$106K ﹤0.01% 4973
2023
Q1
$4.37K Buy
1,337
+701
+110% +$2.75K ﹤0.01% 6085
2022
Q4
$3.2K Buy
636
+179
+39% +$714 ﹤0.01% 5892
2022
Q3
$1K Buy
+457
New +$1.26K ﹤0.01% 6304

Other funds holding CMPX